We are live on !
Find out more
Aperio Group Portfolio holdings
AUM
$33.8B
Turnover
6.32%
1-Year Est. Return
31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$33.8B
AUM Growth
+$4.19B
(+14%)
Cap. Flow
+$264M
Cap. Flow % of AUM
Cap. Flow %
0.78%
Top 10 Holdings %
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Avg Time Held
4.6
years
Top 10 Avg Time Held
3.4
years
Top 20 Avg Time Held
3.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever
UL
|
+$52.4M |
| 2 |
Tesla
TSLA
|
+$42.1M |
| 3 |
Microsoft
MSFT
|
+$16.9M |
| 4 |
Walt Disney
DIS
|
+$14.5M |
| 5 |
Morgan Stanley
MS
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unilever NV New York Registry Shares
UN
|
+$48.8M |
| 2 |
AT&T
T
|
+$25.4M |
| 3 |
Johnson & Johnson
JNJ
|
+$20M |
| 4 |
Amazon
AMZN
|
+$15.7M |
| 5 |
Biogen
BIIB
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.68% |
| 2 | Financials | 13.75% |
| 3 | Healthcare | 13.35% |
| 4 | Consumer Discretionary | 11.59% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2301
Extreme Networks
EXTR
$2.96B
| $204K | ﹤0.01% |
29,645
+2,315
| +8% | +$12.4K |
2016 Q4
16 quarters
|
|
|
VRE
2302
DELISTED
Veris Residential
VRE
| $204K | ﹤0.01% |
16,385
-16,925
| -51% | -$216K |
2014 Q1
27 quarters
|
|
|
FOE
2303
DELISTED
Ferro Corporation
FOE
| $204K | ﹤0.01% |
13,945
+91
| +0.7% | +$1.26K |
2018 Q4
8 quarters
|
|
2304
Precision BioSciences
DTIL
$183M
| $203K | ﹤0.01% |
813
+243
| +43% | +$59.6K |
2020 Q1
3 quarters
|
|
2305
Enova International
ENVA
$4.47B
| $203K | ﹤0.01% |
+8,196
| New | +$168K |
2020 Q4
0 quarters
|
|
2306
DELISTED
Surmodics
SRDX
| $203K | ﹤0.01% |
+4,665
| New | +$184K |
2020 Q4
0 quarters
|
|
2307
DELISTED
Paramount Global Class A
PARAA
| $202K | ﹤0.01% |
+5,354
| New | +$179K |
2020 Q4
0 quarters
|
|
2308
Ecovyst
ECVT
$1.1B
| $199K | ﹤0.01% |
13,953
+892
| +7% | +$11.3K |
2020 Q2
2 quarters
|
|
2309
Transmedics
TMDX
$2.55B
| $199K | ﹤0.01% |
+10,025
| New | +$148K |
2020 Q4
0 quarters
|
|
2310
Aimco
AIV
$240M
| $196K | ﹤0.01% |
37,175
-269,673
| -88% | -$1.2M |
2014 Q1
27 quarters
|
|
|
HOME
2311
DELISTED
At Home Group Inc.
HOME
| $196K | ﹤0.01% |
+12,654
| New | +$220K |
2020 Q4
0 quarters
|
|
|
AVTA
2312
DELISTED
Avantax, Inc. Common Stock
AVTA
| $195K | ﹤0.01% |
+12,282
| New | +$150K |
2020 Q4
0 quarters
|
|
|
RESI
2313
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $195K | ﹤0.01% |
+12,042
| New | +$167K |
2020 Q4
0 quarters
|
|
|
CMO
2314
DELISTED
Capstead Mortgage Corp.
CMO
| $193K | ﹤0.01% |
33,145
-1,168
| -3% | -$6.67K |
2019 Q4
4 quarters
|
|
2315
Yext
YEXT
$702M
| $190K | ﹤0.01% |
+12,088
| New | +$207K |
2020 Q4
0 quarters
|
|
2316
Invesco Mortgage Capital
IVR
$591M
| $189K | ﹤0.01% |
5,595
-1,744
| -24% | -$54K |
2014 Q1
27 quarters
|
|
2317
UMH Properties
UMH
$1.31B
| $187K | ﹤0.01% |
+12,598
| New | +$183K |
2020 Q4
0 quarters
|
|
2318
Orchid Island Capital
ORC
$969M
| $185K | ﹤0.01% |
7,084
+1,255
| +22% | +$33.3K |
2018 Q4
8 quarters
|
|
2319
DELISTED
First of Long Island Corp
FLIC
| $184K | ﹤0.01% |
10,314
-597
| -5% | -$10.1K |
2017 Q4
12 quarters
|
|
2320
OneSpaWorld
OSW
$2.42B
| $183K | ﹤0.01% |
18,032
+2,319
| +15% | +$18.3K |
2020 Q3
1 quarter
|
|
2321
International Seaways
INSW
$5.39B
| $182K | ﹤0.01% |
11,162
-2,706
| -20% | -$43.5K |
2020 Q1
3 quarters
|
|
2322
News Corp Class B
NWS
$18B
| $181K | ﹤0.01% |
10,187
+132
| +1% | +$2.12K |
2020 Q3
1 quarter
|
|
2323
Rigel Pharmaceuticals
RIGL
$896M
| $179K | ﹤0.01% |
5,118
+841
| +20% | +$24.3K |
2019 Q2
6 quarters
|
|
2324
DELISTED
Veren
VRN
| $179K | ﹤0.01% |
76,570
+36,425
| +91% | +$62.3K |
2020 Q3
1 quarter
|
|
|
RUBY
2325
DELISTED
Rubius Therapeutics, Inc
RUBY
| $179K | ﹤0.01% |
23,550
+3,622
| +18% | +$21.5K |
2020 Q1
3 quarters
|
|
Similar funds
LCM
Aperio Group's Q4 2020 Portfolio in Review
As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
- Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
- Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
- Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
- Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
- Aperio Group opened 104 new positions and closed 53 in Q4 2020.
- Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.
Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.